HAEMONETICS CORP - HAE

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 12, 2026 SCHEDULE 13G/A AQR Capital Management, LLC 4.99% 2,266,489 View
Aug 12, 2026 SCHEDULE 13G/A AQR Capital Management Holdings, LLC 4.99% 2,266,489 View
May 13, 2026 SCHEDULE 13G/A North Peak Capital Management, LLC 0.0% 0 View
May 13, 2026 SCHEDULE 13G/A North Peak Capital GP, LLC 0.0% 0 View
May 13, 2026 SCHEDULE 13G/A North Peak Capital Partners, LP 0.0% 0 View
May 13, 2026 SCHEDULE 13G/A North Peak Capital Partners II, LP 0.0% 0 View
May 13, 2026 SCHEDULE 13G/A North Peak Capital Alpha Fund, LP 0.0% 0 View
May 13, 2026 SCHEDULE 13G/A North Peak Capital Ultra Fund, LP 0.0% 0 View
May 13, 2026 SCHEDULE 13G/A Michael Kevin Kahan 0.0% 0 View
May 13, 2026 SCHEDULE 13G/A Jeremy Steven Kahan 0.0% 0 View
Apr 30, 2026 SCHEDULE 13G Vanguard Capital Management 5.26% 2,445,817 View
Apr 29, 2026 SCHEDULE 13G Vanguard Portfolio Management 5.59% 2,600,145 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.